Due to the Coronavirus, Translational Immunology and the satellite BIS meeting were postponed from 26-27 March 2020 to the end of the year. We are happy to confirm the new date: 8-9 December 2020. The aim of this conference is to bridge the translational gap in immunopathology, bringing together clinicians, research scientists and industry partners to discuss prominent advances from the bench to the clinic. The different sessions will have a particular focus on precision medicine in general, starting from disease-oriented cases and lessons learned. Innovative and alternative therapeutic strategies in immune-mediated disorders will be presented, besides the regulatory challenges that companies and researchers are dealing with.

Translational Immunology

8-9 DECEMBER 2020, GHENT, BELGIUM

Due to the Coronavirus, Translational Immunology and the satellite BIS meeting were postponed from 26-27 March 2020 to the end of the year. We are happy to confirm the new date: 8-9 December 2020.

The aim of this conference is to bridge the translational gap in immunopathology, bringing together clinicians, research scientists and industry partners to discuss prominent advances from the bench to the clinic. The different sessions will have a particular focus on precision medicine in general, starting from disease-oriented cases and lessons learned. Innovative and alternative therapeutic strategies in immune-mediated disorders will be presented, besides the regulatory challenges that companies and researchers are dealing with.

Deadlines:

• NEW Abstract submission deadline: 5 October 2020
• Early Bird deadline: 27 October 2020
• Late Registration deadline: 24 November 2020

Speakers:

• Rosa Bacchetta - Stanford Medicine, US
• Dirk Elewaut - VIB-UGent Center for Inflammation Research, BE
• Alain Fischer - Assistance publique – Hôpitaux de Paris, FR
• Martin Guilliams - VIB-UGent Center for Inflammation Research, BE
• Pleun Hombrink - Sanquin, NL
• Bengt Hoepken - Clinical Program Director, UCB Pharma, DE
• Isabelle Huys - KU Leuven, BE
• Christophe Lahorte - National Innovation Office & Scientific-Technical Advice Unit - Federal Agency For Medicines And Healthcare Products (Famhp)
• Bart Lambrecht - VIB-UGent Center for Inflammation Research, BE
• Antonio Lanzavecchia - Institute for Research in Biomedicine, CH
• Sophie Lucas - de Duve Institute, UCLouvain, BE
• Bénédicte Machiels - FARAH Center, ULiège, BE
• Melanie Matheu - CEO, Founder at Prellis Biologics, Inc., US
• Massimiliano Mazzone - VIB-KU Leuven Center for Cancer Biology, BE
• Kathy McCoy - University of Calgary, CA
• Eoin McKinney - University of Cambridge, UK
• Fiona Powrie - Kennedy Institute of Rheumatology, University of Oxford, UK
• Federica Sallusto - Institute for Research in Biomedicine, CH
• Georg Schett - Friedrich-Alexander University Erlangen-Nürnberg, DE
• Marvin van Luijn - Erasmus MC, University Medical Center Rotterdam MS Center ErasMS, NL

Conference website: https://www.vibconferences.be/events/translational-immunology

Location: De Bijloke, Jozef Kluyskensstraat 2, 9000 Gent

Hashtag: #TransImmu20